{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:46:21Z","timestamp":1792197981188,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017585","name":"First Hospital of Jilin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017585","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ginseng Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jgr.2025.03.006","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T11:01:53Z","timestamp":1742554913000},"page":"306-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The antitumor effects and apoptotic mechanism of 20(S)-Protopanaxadiol in acute myeloid leukemia"],"prefix":"10.1016","volume":"49","author":[{"given":"Ye","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saisai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaida","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jgr.2025.03.006_bib1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2174\/1568009620666200424150321","article-title":"The evolving AML genomic landscape: therapeutic implications","volume":"20","author":"Horibata","year":"2020","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.jgr.2025.03.006_bib2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41392-020-00361-x","article-title":"Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy","volume":"5","author":"Carter","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.jgr.2025.03.006_bib3","first-page":"38","article-title":"Acute myeloid leukemia: a review","volume":"103","author":"Pelcovits","year":"2020","journal-title":"R I Med J"},{"issue":"7","key":"10.1016\/j.jgr.2025.03.006_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.jgr.2025.03.006_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","article-title":"Emerging agents and regimens for AML","volume":"14","author":"Liu","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"3","key":"10.1016\/j.jgr.2025.03.006_bib6","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s43440-020-00213-z","article-title":"Ginsenoside from ginseng: a promising treatment for inflammatory bowel disease","volume":"73","author":"Kang","year":"2021","journal-title":"Pharmacol Rep"},{"issue":"7","key":"10.1016\/j.jgr.2025.03.006_bib7","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.apsb.2020.12.017","article-title":"Ginsenosides in Panax genus and their biosynthesis","volume":"11","author":"Hou","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jgr.2025.03.006_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2022.105135","article-title":"Insight on structural modification, biological activity, structure-activity relationship of PPD-type ginsenoside derivatives","volume":"158","author":"Tong","year":"2022","journal-title":"Fitoterapia"},{"issue":"10","key":"10.1016\/j.jgr.2025.03.006_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21101326","article-title":"Saponins from Chinese medicines as anticancer agents","volume":"21","author":"Xu","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.jgr.2025.03.006_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112087","article-title":"Dammarane-type leads panaxadiol and protopanaxadiol for drug discovery: biological activity and structural modification","volume":"189","author":"Wang","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.jgr.2025.03.006_bib11","first-page":"1277","article-title":"20(S)-Protopanaxadiol induces apoptosis in human hepatoblastoma HepG2 cells by downregulating the protein kinase B signaling pathway","volume":"15","author":"Lu","year":"2018","journal-title":"Exp Ther Med"},{"issue":"4","key":"10.1016\/j.jgr.2025.03.006_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041053","article-title":"20(S)-Protopanaxadiol-Induced apoptosis in MCF-7 breast cancer cell line through the inhibition of PI3K\/AKT\/mTOR signaling pathway","volume":"19","author":"Zhang","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jgr.2025.03.006_bib13","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/ijc.27754","article-title":"20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor","volume":"132","author":"Cao","year":"2013","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.jgr.2025.03.006_bib14","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1142\/S0192415X13500778","article-title":"20(S)-protopanaxadiol triggers mitochondrial-mediated apoptosis in human lung adenocarcinoma A549 cells via inhibiting the PI3K\/Akt signaling pathway","volume":"41","author":"Zhang","year":"2013","journal-title":"Am J Chin Med"},{"issue":"3","key":"10.1016\/j.jgr.2025.03.006_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1139\/y04-001","article-title":"Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines, Int-407 and Caco-2","volume":"82","author":"Popovich","year":"2004","journal-title":"Can J Physiol Pharmacol"},{"issue":"11\u201312","key":"10.1016\/j.jgr.2025.03.006_bib16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s10495-022-01756-7","article-title":"c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia","volume":"27","author":"Liu","year":"2022","journal-title":"Apoptosis"},{"issue":"3","key":"10.1016\/j.jgr.2025.03.006_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jnci\/dji026","article-title":"GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia","volume":"97","author":"Ge","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"17","key":"10.1016\/j.jgr.2025.03.006_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cells11172752","article-title":"Inhibition of Mcl-1 synergistically enhances the antileukemic activity of gilteritinib and MRX-2843 in preclinical models of FLT3-mutated acute myeloid leukemia","volume":"11","author":"Wu","year":"2022","journal-title":"Cells"},{"issue":"25","key":"10.1016\/j.jgr.2025.03.006_bib19","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1038\/s41388-019-0768-8","article-title":"A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancer","volume":"38","author":"Bai","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jgr.2025.03.006_bib20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40164-022-00348-0","article-title":"Targeting the integrated stress response in hematologic malignancies","volume":"11","author":"Nwosu","year":"2022","journal-title":"Exp Hematol Oncol"},{"issue":"6","key":"10.1016\/j.jgr.2025.03.006_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2174\/1566524016666160523143937","article-title":"The role of the PERK\/eIF2\u03b1\/ATF4\/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress","volume":"16","author":"Rozpedek","year":"2016","journal-title":"Curr Mol Med"},{"issue":"6","key":"10.1016\/j.jgr.2025.03.006_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"10.1016\/j.jgr.2025.03.006_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167378","article-title":"Apoptosis, pyroptosis, and necroptosis-oh my! The many ways a cell can die","volume":"434","author":"Ketelut-Carneiro","year":"2022","journal-title":"J Mol Biol"},{"issue":"6","key":"10.1016\/j.jgr.2025.03.006_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062841","article-title":"Co-operativity between MYC and BCL-2 pro-survival proteins in cancer","volume":"22","author":"Fairlie","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.jgr.2025.03.006_bib25","article-title":"Resistance mechanism of acute myeloid leukemia cells against daunorubicin and cytarabine: a literature review","volume":"14","author":"Arwanih","year":"2022","journal-title":"Cureus"},{"issue":"1\u20132","key":"10.1016\/j.jgr.2025.03.006_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejphar.2011.06.008","article-title":"20(S)-Protopanaxadiol, a metabolite of ginsenosides, induced cell apoptosis through endoplasmic reticulum stress in human hepatocarcinoma HepG2 cells","volume":"668","author":"Zhu","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.1016\/j.jgr.2025.03.006_bib27","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1158\/1535-7163.MCT-14-0330","article-title":"Suppression of feedback loops mediated by PI3K\/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance","volume":"13","author":"Rozengurt","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"34","key":"10.1016\/j.jgr.2025.03.006_bib28","doi-asserted-by":"crossref","first-page":"56698","DOI":"10.18632\/oncotarget.18082","article-title":"Inhibition of the PI3K\/AKT\/mTOR pathway activates autophagy and compensatory Ras\/Raf\/MEK\/ERK signalling in prostate cancer","volume":"8","author":"Butler","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jgr.2025.03.006_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","article-title":"RAF-MEK-ERK pathway in cancer evolution and treatment","volume":"85","author":"Ullah","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jgr.2025.03.006_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41392-018-0008-7","article-title":"Targeting oncogenic Myc as a strategy for cancer treatment","volume":"3","author":"Chen","year":"2018","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"10.1016\/j.jgr.2025.03.006_bib31","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.15252\/embr.201642195","article-title":"The integrated stress response","volume":"17","author":"Pakos-Zebrucka","year":"2016","journal-title":"EMBO Rep"},{"issue":"2","key":"10.1016\/j.jgr.2025.03.006_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.beha.2019.05.008","article-title":"Venetoclax-based therapies for acute myeloid leukemia","volume":"32","author":"Guerra","year":"2019","journal-title":"Best Pract Res Clin Haematol"},{"issue":"6","key":"10.1016\/j.jgr.2025.03.006_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061292","article-title":"Targeting BCL-2 in cancer: advances, challenges, and perspectives","volume":"13","author":"Hafezi","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jgr.2025.03.006_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-015-0224-3","article-title":"ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development","volume":"8","author":"Cang","year":"2015","journal-title":"J Hematol Oncol"}],"container-title":["Journal of Ginseng Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1226845325000302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1226845325000302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:31:53Z","timestamp":1762367513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1226845325000302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1226845325000302"],"URL":"https:\/\/doi.org\/10.1016\/j.jgr.2025.03.006","relation":{},"ISSN":["1226-8453"],"issn-type":[{"value":"1226-8453","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antitumor effects and apoptotic mechanism of 20(S)-Protopanaxadiol in acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Ginseng Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgr.2025.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Korean Society of Ginseng. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}